Wistar researchers successfully evaluated a simple intervention that could unlock higher anti-tumour potential in T-cell therapies, a strategy known as "cell-based therapy," which uses specifically tailored T cells to combat cancer.
Chennai (Tamil Nadu) [India], December 28: Kauvery Hospital Main Alwarpet, a unit of Kauvery Group of Hospitals, successfully removed a complex spinal cord tumour. The surgery which lasted for 28 hours was performed by a multidisciplinary team of surgeons marking a significant milestone in t
Ahmedabad (Gujarat) [India], December 20: Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical company, has announced today a strategic exclusive licensing agreement with mAbxience (a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma) for a biosimilar
MIT researchers have created a patch-like wearable ultrasound monitor that can inspect organs within the body without the need for an ultrasound operator or the use of gel.
MIT researchers have developed a patch-like wearable ultrasound monitor that can inspect organs within the body without the necessity of an ultrasound operator or the application of the gel.
MIT researchers have created a patch-like wearable ultrasound monitor that can examine organs within the body without the use of an ultrasound operator or the application of the gel.
Pancreatic cancer is difficult to treat because it spreads quickly and has a distinct biochemical makeup. However, researchers achieved a significant advance by discovering the genetic changes that occur during tumour migration -- and they also discovered a medication that may block the proc
New research led by NYU Langone Health and its Perlmutter Cancer Centre suggested that rather than analyzing the tumours themselves, genetic data from seemingly healthy tissue close to lung tumours may be a better indicator of whether cancer will recur after treatment.
According to new research headed by NYU Langone Health and its Perlmutter Cancer Centre, genetic information taken from seemingly healthy tissue near lung tumours may be a better predictor of whether cancer will return following therapy than analysis of the tumours themselves.
In theory, a team from the University of Massachusetts Amherst proved that a protein antigen from a childhood vaccine may be administered into the cells of a malignant tumour to reorient the body's immune system against the cancer, effectively stopping it and preventing its recurrence.